ArticleEuropean urology2021

Corrigendum re "Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma" [Eur Urol 2020;78:907-15].

Min Yuen Teo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.